Anebulo Pharmaceuticals, Inc. SEC filings ANEB

Anebulo Pharmaceuticals, Inc. has 204 filings in SEC EDGAR's recent list, going back to Jun 25, 2020. Its latest annual report, Form 10-K, was filed on Sep 29, 2025 for the period ended Jun 30, 2025. The latest quarterly report (Form 10-Q) was filed on Feb 12, 2026, covering the quarter ended Dec 31, 2025. The most recent current report (Form 8-K) was filed on Feb 12, 2026 (results of operations). The company's fiscal year ends on June 30.

Form Description Filed Period
10-Q Quarterly report Feb 12, 2026 Dec 31, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
10-Q Quarterly report Feb 14, 2025 Dec 31, 2024
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
10-Q Quarterly report Feb 13, 2024 Dec 31, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
10-Q Quarterly report Feb 10, 2023 Dec 31, 2022
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
10-Q Quarterly report May 11, 2022 Mar 31, 2022
10-Q Quarterly report Feb 11, 2022 Dec 31, 2021
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
10-Q Quarterly report Jun 21, 2021 Mar 31, 2021

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ANEB (OTC)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
Lakeway, TX
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1815974

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.